Patients with Rare, Life Threatening Diseases Meet With Minnesota State Legislators
April 23, 2008
April 23, 2008
ST. PAUL, Minn., April 23 -- The Plasma Protein Therapeutics Association issued the following news release:
Today, individuals with primary immune deficiency diseases, hemophilia and alpha-1 antitrypsin deficiency will meet with state legislators to educate them on the need for a health care system that ensures them access to the life-saving therapies they need.
Known collectively as plasma protein therapies, plasma-derived and recombinant biological therapies are . . .
Today, individuals with primary immune deficiency diseases, hemophilia and alpha-1 antitrypsin deficiency will meet with state legislators to educate them on the need for a health care system that ensures them access to the life-saving therapies they need.
Known collectively as plasma protein therapies, plasma-derived and recombinant biological therapies are . . .